Host: Lauren Streicher, MD Guest: Sharmila Makhija, MD We are finding the highest prevalence of human papillomavirus (HPV) among women in their early 20s, but the FDA now recommends that an HPV vaccine be administered to women up to the age of 45. Why? Because recent research tells us that the at-risk population may be larger than we think. Dr. Sharmila Makhija, associate professor of gynecologic oncology at Emory University School of Medicine, weighs the pros and cons of this new recommendation with host Dr. Lauren Streicher.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast